SG Americas Securities LLC Boosts Holdings in Humana Inc. $HUM

SG Americas Securities LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 51.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 39,220 shares of the insurance provider’s stock after buying an additional 13,387 shares during the quarter. SG Americas Securities LLC’s holdings in Humana were worth $10,204,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Elevation Point Wealth Partners LLC purchased a new position in Humana in the second quarter worth approximately $32,000. Mather Group LLC. acquired a new position in shares of Humana in the 3rd quarter valued at $34,000. AlphaCore Capital LLC acquired a new position in shares of Humana in the 2nd quarter valued at $39,000. Private Wealth Management Group LLC grew its holdings in shares of Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. increased its position in shares of Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 0.3%

NYSE HUM opened at $276.79 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The firm has a market cap of $33.29 billion, a price-to-earnings ratio of 25.94, a PEG ratio of 2.29 and a beta of 0.45. The firm has a 50 day simple moving average of $254.30 and a 200-day simple moving average of $262.31. Humana Inc. has a one year low of $206.87 and a one year high of $315.35.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same period in the prior year, the business earned $4.16 EPS. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. Equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana’s dividend payout ratio (DPR) is 33.18%.

Analyst Ratings Changes

HUM has been the topic of a number of recent analyst reports. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Jefferies Financial Group raised shares of Humana from a “hold” rating to a “buy” rating and boosted their price target for the company from $253.00 to $313.00 in a research note on Friday, December 5th. Robert W. Baird decreased their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a report on Thursday, December 11th. Wolfe Research lowered their price objective on shares of Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a research report on Thursday, November 20th. Finally, Wells Fargo & Company lowered Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat, Humana has an average rating of “Hold” and an average target price of $292.05.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.